Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor κB activation

Journal of Biological Chemistry

Volumn 288, Issue 38, 2013, Pages 27667-27679

  Adada, Mohamad M ^a   Alexa Orr Gandy, K ^b   Snider, Ashley J ^a,c   Canals, Daniel ^a   Hannun, Yusuf A ^a   Obeid, Lina M ^a,c   Clarke, Christopher J ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORY FUNCTION; NUCLEAR FACTORS; NUCLEAR TRANSLOCATIONS; P38 MITOGEN-ACTIVATED PROTEIN KINASE; SPHINGOLIPIDS; SPHINGOSINE 1 PHOSPHATES; SPHINGOSINE KINASE; TUMOR NECROSIS;

ACTIVATION ANALYSIS; ENZYMES; GENE EXPRESSION; PHOSPHORYLATION;

SPHINGOSINES;

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; RANTES; SMALL INTERFERING RNA; SPHINGOSINE KINASE 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOKINESIS; CONTROLLED STUDY; HELA CELL; IMMUNOREGULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSLATION REGULATION; UPREGULATION;

CHEMOKINES; INFLAMMATION; NF-KAPPA B (NF-KB); P38 MAPK; RANTES; SPHINGOSINE KINASE; SPHINGOSINE-1-PHOSPHATE; TUMOR NECROSIS FACTOR (TNF);

ANIMALS; CHEMOKINE CCL5; ENZYME ACTIVATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; MICE; MICE, KNOCKOUT; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884584558     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.489443     Document Type: Article

References (70)

1. Hannun, Y. A., and Obeid, L. M. (2008) Principles of bioactive lipid signalling. Lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139-150
2. Deutschman, D. H., Carstens, J. S., Klepper, R. L., Smith, W. S., Page, M. T., Young, T. R., Gleason, L. A., Nakajima, N., and Sabbadini, R. A. (2003) Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am. Heart J. 146, 62-68
3. Yung, L. M., Wei, Y., Qin, T., Wang, Y., Smith, C. D., and Waeber, C. (2012) Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. Stroke 43, 199-204
4. Park, S. W., Kim, M., Brown, K. M., D'Agati, V. D., and Lee, H. T. (2012) Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 23, 266-280
5. Selvam, S. P., and Ogretmen, B. (2013) Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. Handb. Exp. Pharmacol. 216, 3-27
6. Pitson, S. M., Moretti, P. A., Zebol, J. R., Lynn, H. E., Xia, P., Vadas, M. A., and Wattenberg, B. W. (2003) Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22, 5491-5500
7. Strub, G. M., Paillard, M., Liang, J., Gomez, L., Allegood, J. C., Hait, N. C., Maceyka, M., Price, M. M., Chen, Q., Simpson, D. C., Kordula, T., Milstien, S., Lesnefsky, E. J., and Spiegel, S. (2011) Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25, 600-612
8. Hisano, Y., Kobayashi, N., Yamaguchi, A., and Nishi, T. (2012) Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One 7, e38941
9. Nijnik, A., Clare, S., Hale, C., Chen, J., Raisen, C., Mottram, L., Lucas, M., Estabel, J., Ryder, E., Adissu, H., Sanger Mouse Genetics Project, Adams, N. C., Ramirez-Solis, R., White, J. K., Steel, K. P., Dougan, G., and Hancock, R. E. (2012) The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J. Immunol. 189, 102-111
10. Aarthi, J. J., Darendeliler, M. A., and Pushparaj, P. N. (2011) Dissecting the role of the S1P/S1PR axis in health and disease. J. Dent. Res. 90, 841-854
11. Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., Milstien, S., and Spiegel, S. (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088
12. Sawada, M., Kiyono, T., Nakashima, S., Shinoda, J., Naganawa, T., Hara, S., Iwama, T., and Sakai, N. (2004) Molecular mechanisms of TNF-α-induced ceramide formation in human glioma cells. p53-mediated oxidant stressdependent and -independent pathways. Cell Death Differ. 11, 997-1008
13. Osawa, Y., Banno, Y., Nagaki, M., Brenner, D. A., Naiki, T., Nozawa, Y., Nakashima, S., and Moriwaki, H. (2001) TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J. Immunol. 167, 173-180
14. Clarke, C. J., Cloessner, E. A., Roddy, P. L., and Hannun, Y. A. (2011) Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells. Biochem. J. 435, 381-390
15. Clarke, C. J., Truong, T. G., and Hannun, Y. A. (2007) Role for neutral sphingomyelinase-2 in tumor necrosis factor α-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells. p38 MAPK is an upstream regulator of nSMase2. J. Biol. Chem. 282, 1384-1396
16. Jenkins, R. W., Clarke, C. J., Canals, D., Snider, A. J., Gault, C. R., Heffernan-Stroud, L., Wu, B. X., Simbari, F., Roddy, P., Kitatani, K., Obeid, L. M., and Hannun, Y. A. (2011) Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. J. Biol. Chem. 286, 13292-13303
17. Levy, J. A. (2009) The unexpected pleiotropic activities of RANTES. J. Immunol. 182, 3945-3946
18. Maune, S., Berner, I., Sticherling, M., Kulke, R., Bartels, J., and Schröder, J. M. (1996) Fibroblasts but not epithelial cells obtained from human nasal mucosa produce the chemokine RANTES. Rhinology 34, 210-214
19. Casola, A., Henderson, A., Liu, T., Garofalo, R. P., and Brasier, A. R. (2002) Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L1280-L1290
20. Kovacic, J. C., Gupta, R., Lee, A. C., Ma, M., Fang, F., Tolbert, C. N., Walts, A. D., Beltran, L. E., San, H., Chen, G., St Hilaire, C., and Boehm, M. (2010) STAT3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J. Clin. Invest. 120, 303-314
21. Krohn, R., Raffetseder, U., Bot, I., Zernecke, A., Shagdarsuren, E., Liehn, E. A., Van Santbrink, P. J., Nelson, P. J., Biessen, E. A., Mertens, P. R., and Weber, C. (2007) Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 116, 1812-1820
22. Charni, F., Friand, V., Haddad, O., Hlawaty, H., Martin, L., Vassy, R., Oudar, O., Gattegno, L., Charnaux, N., and Sutton, A. (2009) Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochim. Biophys. Acta 1790, 1314-1326
23. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., and Weinberg, R. A. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563
24. Herder, C., Illig, T., Baumert, J., Müller, M., Klopp, N., Khuseyinova, N., Meisinger, C., Poschen, U., Martin, S., Koenig, W., and Thorand, B. (2008) RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes. Results from the MONICA/KORA Augsburg casecohort study, 1984-2002. Eur. J. Endocrinol. 158, R1-R5
25. Krensky, A. M., and Ahn, Y. T. (2007) Mechanisms of disease. Regulation of RANTES (CCL5) in renal disease. Nat. Clin. Pract Nephrol. 3, 164-170
26. Boiardi, L., Macchioni, P., Meliconi, R., Pulsatelli, L., Facchini, A., and Salvarani, C. (1999) Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin. Exp. Rheumatol. 17, 419-425
27. Tyner, J. W., Uchida, O., Kajiwara, N., Kim, E. Y., Patel, A. C., O'Sullivan, M. P., Walter, M. J., Schwendener, R. A., Cook, D. N., Danoff, T. M., and Holtzman, M. J. (2005) CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med. 11, 1180-1187
28. Hao, S., and Baltimore, D. (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 10, 281-288
29. Homma, T., Matsukura, S., Hirose, T., Ohnishi, T., Kimura, T., Kurokawa, M., Ieki, K., Odaka, M., Suzuki, S., Watanabe, S., Sato, M., Kawaguchi, M., Schleimer, R. P., and Adachi, M. (2010) Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-α or interferon-γ through nuclear factor-κB or STAT-1 in airway epithelial cells. Int. Arch. Allergy Immunol. 152, 9-17
30. Matsuzaki, S., Ishizuka, T., Hisada, T., Aoki, H., Komachi, M., Ichimonji, I., Utsugi, M., Ono, A., Koga, Y., Dobashi, K., Kurose, H., Tomura, H., Mori, M., and Okajima, F. (2010) Lysophosphatidic acid inhibits CC chemokine ligand 5/RANTES production by blocking IRF-1-mediated gene transcription in human bronchial epithelial cells. J. Immunol. 185, 4863-4872
31. Ammit, A. J., Lazaar, A. L., Irani, C., O'Neill, G. M., Gordon, N. D., Amrani, Y., Penn, R. B., and Panettieri, R. A., Jr. (2002) Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells. Modulation by glucocorticoids and β-agonists. Am. J. Respir. Cell Mol. Biol. 26, 465-474
32. Kumar, D., Hosse, J., Von Toerne, C., Noessner, E., and Nelson, P. J. (2009) JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1. J. Immunol. 182, 1011-1020
33. Wong, C. K., Tsang, C. M., Ip, W. K., and Lam, C. W. (2006) Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-α. Roles of ERK, p38 MAPK, and NF-κB. Allergy 61, 289-297
34. Liu, H., Ning, H., Men, H., Hou, R., Fu, M., Zhang, H., and Liu, J. (2012) Regulation of CCL5 expression in smooth muscle cells following arterial injury. PLoS One 7, e30873
35. Heffernan-Stroud, L. A., Helke, K. L., Jenkins, R. W., De Costa, A. M., Hannun, Y. A., and Obeid, L. M. (2012) Defining a role for sphingosine kinase 1 in p53-dependent tumors. Oncogene 31, 1166-1175
36. Canals, D., Jenkins, R. W., Roddy, P., Hernández-Corbacho, M. J., Obeid, L. M., and Hannun, Y. A. (2010) Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation. Probing sphingolipid signaling at the outer plasma membrane. J. Biol. Chem. 285, 32476-32485
37. Neubauer, H. A., and Pitson, S. M. (2013) Roles, regulation and inhibitors of sphingosine kinase 2. FEBS J., in press
38. McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., and Jones, S. A. (2005) IL-6 transsignaling via STAT3 directs T cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. U. S. A. 102, 9589-9594
39. Werts, C., Le Bourhis, L., Liu, J., Magalhaes, J. G., Carneiro, L. A., Fritz, J. H., Stockinger, S., Balloy, V., Chignard, M., Decker, T., Philpott, D. J., Ma, X., and Girardin, S. E. (2007) Nod1 and Nod2 induce CCL5/RANTES through the NF-κB pathway. Eur. J. Immunol. 37, 2499-2508
40. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., and Gerritsen, M. E. (1997) Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272, 21096-21103
41. Xia, P., Wang, L., Moretti, P. A., Albanese, N., Chai, F., Pitson, S. M., D'Andrea, R. J., Gamble, J. R., and Vadas, M. A. (2002) Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J. Biol. Chem. 277, 7996-8003
42. Verhelst, K., Carpentier, I., and Beyaert, R. (2011) Regulation of TNFinduced NF-κB activation by different cytoplasmic ubiquitination events. Cytokine Growth Factor Rev. 22, 277-286
43. Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., and Hannun, Y. A. (2003) The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α. FASEB J. 17, 1411-1421
44. Dejardin, E. (2006) The alternative NF-κB pathway from biochemistry to biology. Pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161-1179
45. Zhou, F. H., Foster, B. K., Zhou, X. F., Cowin, A. J., and Xian, C. J. (2006) TNF-α mediates p38MAPkinase activation and negatively regulates bone formation at the injured growth plate in rats. J. Bone Miner Res. 21, 1075-1088
46. Kilpatrick, L. E., Sun, S., Mackie, D., Baik, F., Li, H., and Korchak, H. M. (2006) Regulation of TNF mediated antiapoptotic signaling in human neutrophils. Role of δ-PKC and ERK1/2. J. Leukocyte Biol. 80, 1512-1521
47. Schenten, V., Melchior, C., Steinckwich, N., Tschirhart, E. J., and Bréchard, S. (2011) Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9. J. Leukocyte Biol. 89, 587-596
48. Kozawa, O., Niwa, M., Matsuno, H., Tokuda, H., Miwa, M., Ito, H., Kato, K., and Uematsu, T. (1999) Sphingosine 1-phosphate induces heat shock protein 27 via p38 mitogen-activated protein kinase activation in osteoblasts. J. Bone Miner. Res. 14, 1761-1767
49. Cheon, S., Song, S. B., Jung, M., Park, Y., Bang, J. W., Kim, T. S., Park, H., Kim, C. H., Yang, Y. H., Bang, S. I., and Cho, D. (2008) Sphingosine kinase inhibitor suppresses IL-18-induced interferon-γ production through inhibition of p38 MAPK activation in human NK cells. Biochem. Biophys. Res. Commun. 374, 74-78
50. Kim, M. O., Suh, H. S., Brosnan, C. F., and Lee, S. C. (2004) Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β. J. Neurochem. 90, 297-308
51. Melchjorsen, J., and Paludan, S. R. (2003) Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor κB and interferon regulatory factor 3. J. Gen Virol. 84, 2491-2495
52. Iwano, S., Asaoka, Y., Akiyama, H., Takizawa, S., Nobumasa, H., Hashimoto, H., and Miyamoto, Y. (2011) A possible mechanism for hepatotoxicity induced by BIRB-796, an orally active p38 mitogen-activated protein kinase inhibitor. J. Appl Toxicol. 31, 671-677
53. Baeza-Raja, B., and Muñoz-Cánoves, P. (2004) p38 MAPK-induced nuclear factor-κB activity is required for skeletal muscle differentiation. Role of interleukin-6. Mol. Biol. Cell 15, 2013-2026
54. Craig, R., Larkin, A., Mingo, A. M., Thuerauf, D. J., Andrews, C., Mc-Donough, P. M., and Glembotski, C. C. (2000) p38 MAPK and NF-κB collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J. Biol. Chem. 275, 23814-23824
55. Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., and Spiegel, S. (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254-1257
56. French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., and Smith, C. D. (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962-5969
57. Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T. W., Yagita, H., Okumura, K., Yeh, W. C., and Nakano, H. (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276, 36530-36534
58. Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P., and Fiers, W. (1996) The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15, 1914-1923
59. Glass, C. K., and Witztum, J. L. (2001) Atherosclerosis. The road ahead. Cell 104, 503-516
60. Cuadrado, A., and Nebreda, A. R. (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417
61. Kefaloyianni, E., Gaitanaki, C., and Beis, I. (2006) ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblasts. Cell Signal. 18, 2238-2251
62. Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W., and Haegeman, G. (2003) Transcriptional activation of the NF-κB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J. 22, 1313-1324
63. Saccani, S., Pantano, S., and Natoli, G. (2002) p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3, 69-75
64. Yagasaki, Y., Sudo, T., and Osada, H. (2004) Exip, a splicing variant of p38α, participates in interleukin-1 receptor proximal complex and downregulates NF-κB pathway. FEBS Lett. 575, 136-140
65. Cheung, P. C., Campbell, D. G., Nebreda, A. R., and Cohen, P. (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22, 5793-5805
66. Au, P. Y., and Yeh, W. C. (2007) Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv. Exp. Med. Biol. 597, 32-47
67. Liu, M., Guo, S., and Stiles, J. K. (2011) The emerging role of CXCL10 in cancer (Review). Oncol. Lett. 2, 583-589
68. Anelli, V., Gault, C. R., Snider, A. J., and Obeid, L. M. (2010) Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. FASEB J. 24, 2727-2738
69. Ghadjar, P., Rubie, C., Aebersold, D. M., and Keilholz, U. (2009) The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 125, 741-745
70. Dhawan, P., and Richmond, A. (2002) Role of CXCL1 in tumorigenesis of melanoma. J. Leukocyte Biol. 72, 9-18